4 Results for "

NCI-H1581

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "NCI-H1581" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-114311
CAS No.: 2308497-58-5
Purity:  98.26%
Research Areas:  

Cancer

FGFR1/DDR2 inhibitor 1 is an orally active inhibitor of fibroblast growth factor receptor 1 (FGFR1) and discoindin domain receptor 2 (DDR2), with IC50 values of 31.1 nM and 3.2 nM, respectively. Antitumor activity .
loading...
    loading...
Cat. No.: HY-149843
CAS No.: 2828438-38-4
Purity:  99.23%
Target:  

PROTACs FGFR

Research Areas:  

Cancer

LC-MB12 is an orally active PROTAC compound targets FGFR2 degradation with a DC50 of 11.8 nM. LC-MB12 contains BGJ398 (a FGFR2 inhibitor), PROTAC linker and CRBN.LC-MB12 inhibits FGFR2 signaling in gastric cancer cells and has anti-tumor activity .
loading...
    loading...
Cat. No.: HY-174981
Research Areas:  

Cancer

LC-MF-4 is an orally active VHL-recruiting FGFR3 PROTAC degrader and hERG potassium channel inhibitor. LC-MF-4 has an IC50 of 16.6 nM against human FGFR3, exhibits inhibitory activity against hERG potassium channels, suppresses the expression of genes related to mitochondrial biogenesis and ATP synthesis, inhibits cancer cell proliferation, and shows significant antitumor activity in mice. LC-MF-4 can be used in the research of bladder cancer, urothelial carcinoma, FGFR3 Y373C mutant cancers, and FGFR3-TACC3 fusion-positive cancers .
loading...
    loading...
Cat. No.: HY-155028
CAS No.: 2658488-68-5
Target:  

FGFR

Research Areas:  

Cancer

FGFR-IN-11 (compound I-5) is an orally active and covalent FGFR inhibitor with IC50 values of 9.9 nM (FGFR1), 3.1 nM (FGFR2), 16 nM (FGFR3), and 1.8 nM (FGFR4), respectively. FGFR-IN-11 inhibits multiple cancer cell proliferation with nanomolar activity. FGFR-IN-11 inhibits tumor growth significantly in xenograft mice models .
loading...
    loading...